With the Allergan acquisition, we are bringing together more than 30 brands and leadership positions to expand and diversify our product portfolio.  This allows us to have immediate scale and profitability to advance our innovative science pipeline that brings patients groundbreaking medicines across a wide spectrum of therapeutic need/critical therapeutic areas.

We continue to build a sustainable company for the long term that provides profitable growth for shareholders, as well as financial flexibility to invest and expand in order to help address the needs of people and communities around the world. 

Resources

AbbVie is currently reviewing all content on Allergan.com.  As we work through the successful integration of Allergan and consolidation of content, information will be updated.